|
EP1368336A2
|
|
Thiophene substituted amine derivatives as glyt-1 inhibitors
|
|
AU8933601A
|
|
Human glycine transporter
|
|
US6103743A
|
|
Unsaturated amino acid derivatives
|
|
US6162824A
|
|
Tricylic amino-acid derivatives
|
|
US6166072A
|
|
Amino acid derivatives
|
|
AU2599099A
|
|
Tricyclic compounds as glycine transport inhibitors
|
|
AU2030999A
|
|
Glycine transport inhibitors
|
|
US6191165B1
|
|
Pharmaceutical for treatment of neurological and neuropsychiatric disorders
|
|
US6001854A
|
|
Pharmaceutical for treating of neurological and neuropsychiatric disorders
|
|
CA2254835A1
|
|
Glycine transporter-transfected cells and uses thereof
|
|
AU3151097A
|
|
Pharmaceutical for treating of neurological and neuropsychiatric disorders
|
|
AU3153097A
|
|
Pharmaceutical for treatment of neurological and neuropsychiatric disorders
|
|
US6008015A
|
|
Glycine transporter
|
|
US5919653A
|
|
Nucleic acids encoding a human glycine transporter
|
|
US5824486A
|
|
Glycine transporter-transfected cells and uses thereof
|
